It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor.
But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a comprehensive, global research review of how deep learning and GPU-accelerated ... Show More
Jun 24
Inside Instacart's AI-Powered Smart Shopping Cart | NVIDIA AI Podcast Ep. 302
Instacart has 1.6 billion lifetime grocery orders—and is now using that data flywheel to digitize the physical store itself. In this episode, David McIntosh, Chief Connected Stores Officer at Instacart, explains how the Caper Cart—powered by an NVIDIA Jetson™ board and a sensor f ... Show More
39m 55s
Jun 10
How Mistral Is Building Frontier AI for the Enterprise | NVIDIA AI Podcast Ep. 301
Open-weight models are closing the gap with proprietary AI — and Timothée Lacroix, cofounder and CTO of Mistral, has been betting on that since day one. In this episode, he explains why open weights accelerate enterprise adoption, how Mistral is bringing model customization into ... Show More
21m 33s
May 27
Everyone Can Build a Robot: Open Source Embodied AI With Seeed Studio | NVIDIA AI Podcast Ep. 300
Seeed Studio is a leader in open source robotics, delivering affordable NVIDIA Jetson‑powered arms that put embodied AI into the hands of millions of makers, students, and small businesses. In this episode, Seeed Studio CEO Eric Pan and Head of Robotics Elaine Wu explain how open ... Show More
29m 4s
Mar 2025
Episode 54: Can AI Transform Drug Development? With Dr Scott Chetham, CEO of Faro Health
It’s widely assumed that drug treatment is a miracle of modern science. However, it’s equally arguable that modern drug treatment is a very expensive disaster, with serious consequences for public health. For example, a drug typically takes 10-12 years to develop and the cost is ... Show More
34m 33s
Jul 2023
Nvidia Invests $50M into AI Drug Discovery Firm Recursion
In this episode, we delve into Nvidia's substantial $50M investment in Recursion, a leading firm in AI drug discovery. We'll explore the strategic implications of this partnership, discuss how it might accelerate the application of AI in pharmaceutical research, and consider its ... Show More
10m 37s
